Olof Skoldenberg: Clinical Trials

1 trial sponsored by Olof Skoldenberg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Olof Skoldenberg: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Denosumab for Treating Periprosthetic Osteolysis.
Denosumab, Placebo - Osteolysis
Phase 2UnknownOlof Skoldenberg202015-08-012019-02-07

Conditions studied

Osteolysis (1)

Interventions

Denosumab (1)

Countries

Sweden (1)

Results publications

PMID 27108405, PMID 40200363